Nautilus Biotechnology, Inc.

SEC 4 · Filed

0001797672-26-000004Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 18, 2026

Grant, award or other acquisition by Akinsanya Karen

Security
Stock Option (Right to Buy)
Code
A
Shares
45,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-18",
  "direction": "A",
  "exercise_price": "2.28",
  "expiration": "2036-06-18",
  "footnotes": {
    "F1": "Subject to reporting person\u0027s continuous status as a \"Service Provider\" (as defined in the the Issuer\u0027s 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month)."
  },
  "owners": [
    {
      "cik": "0001797672",
      "name": "Akinsanya Karen",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "45000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "45000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "45000"
}